A detailed history of Jennison Associates LLC transactions in Dexcom Inc stock. As of the latest transaction made, Jennison Associates LLC holds 388,797 shares of DXCM stock, worth $28.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
388,797
Previous 388,302 0.13%
Holding current value
$28.1 Million
Previous $53.9 Million 18.15%
% of portfolio
0.03%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$110.31 - $140.45 $54,603 - $69,522
495 Added 0.13%
388,797 $44.1 Million
Q1 2024

May 02, 2024

BUY
$114.22 - $140.1 $1.17 Million - $1.43 Million
10,217 Added 2.7%
388,302 $53.9 Million
Q4 2023

Feb 01, 2024

SELL
$75.49 - $124.16 $295 Million - $486 Million
-3,914,081 Reduced 91.19%
378,085 $46.9 Million
Q3 2023

Oct 31, 2023

SELL
$86.06 - $137.93 $257 Million - $412 Million
-2,990,021 Reduced 41.06%
4,292,166 $400 Million
Q2 2023

Aug 03, 2023

BUY
$112.47 - $130.98 $1.93 Million - $2.25 Million
17,192 Added 0.24%
7,282,187 $936 Million
Q1 2023

Apr 26, 2023

SELL
$104.0 - $122.92 $200 Million - $236 Million
-1,921,227 Reduced 20.91%
7,264,995 $844 Million
Q4 2022

Feb 09, 2023

BUY
$84.98 - $122.67 $191 Million - $275 Million
2,242,846 Added 32.3%
9,186,222 $1.04 Billion
Q3 2022

Nov 01, 2022

SELL
$76.35 - $94.18 $124 Million - $153 Million
-1,620,235 Reduced 18.92%
6,943,376 $559 Million
Q2 2022

Aug 02, 2022

BUY
$67.99 - $132.89 $405 Million - $792 Million
5,963,328 Added 229.33%
8,563,611 $638 Million
Q1 2022

May 11, 2022

BUY
$94.08 - $130.2 $111 Million - $154 Million
1,182,632 Added 83.42%
2,600,283 $1.33 Billion
Q4 2021

Feb 08, 2022

SELL
$129.87 - $162.82 $16.4 Million - $20.5 Million
-126,206 Reduced 8.17%
1,417,651 $761 Million
Q3 2021

Nov 09, 2021

SELL
$106.71 - $143.18 $5.74 Million - $7.71 Million
-53,835 Reduced 3.37%
1,543,857 $844 Million
Q2 2021

Aug 12, 2021

SELL
$80.99 - $107.93 $8.36 Million - $11.1 Million
-103,192 Reduced 6.07%
1,597,692 $682 Million
Q1 2021

May 11, 2021

SELL
$84.79 - $104.74 $24.5 Million - $30.3 Million
-289,338 Reduced 14.54%
1,700,884 $611 Million
Q4 2020

Feb 05, 2021

SELL
$78.0 - $104.5 $58.3 Million - $78.1 Million
-747,643 Reduced 27.31%
1,990,222 $736 Million
Q3 2020

Nov 04, 2020

SELL
$95.51 - $112.95 $2.3 Million - $2.72 Million
-24,091 Reduced 0.87%
2,737,865 $1.13 Billion
Q2 2020

Aug 06, 2020

BUY
$62.68 - $105.34 $4.29 Million - $7.2 Million
68,369 Added 2.54%
2,761,956 $1.12 Billion
Q1 2020

May 06, 2020

SELL
$47.79 - $75.63 $36.6 Million - $57.9 Million
-765,171 Reduced 22.12%
2,693,587 $725 Million
Q4 2019

Feb 07, 2020

SELL
$36.62 - $57.29 $21.3 Million - $33.3 Million
-580,833 Reduced 14.38%
3,458,758 $757 Million
Q3 2019

Nov 08, 2019

BUY
$35.53 - $43.8 $94.1 Million - $116 Million
2,647,611 Added 190.2%
4,039,591 $151 Million
Q2 2019

Aug 06, 2019

BUY
$27.84 - $38.92 $26.3 Million - $36.8 Million
944,642 Added 211.17%
1,391,980 $0
Q1 2019

May 10, 2019

BUY
$28.07 - $38.18 $361,850 - $492,178
12,891 Added 2.97%
447,338 $53.3 Million
Q4 2018

Feb 06, 2019

SELL
$26.99 - $37.37 $2.31 Million - $3.2 Million
-85,688 Reduced 16.47%
434,447 $52 Million
Q3 2018

Nov 08, 2018

SELL
$23.35 - $36.72 $2.44 Million - $3.84 Million
-104,635 Reduced 16.75%
520,135 $74.4 Million
Q2 2018

Aug 02, 2018

SELL
$17.54 - $25.22 $6.19 Million - $8.9 Million
-352,739 Reduced 36.09%
624,770 $59.3 Million
Q1 2018

Apr 20, 2018

SELL
$13.06 - $18.54 $3.93 Million - $5.57 Million
-300,690 Reduced 23.52%
977,509 $72.5 Million
Q4 2017

Jan 25, 2018

SELL
$11.12 - $15.38 $4.49 Million - $6.21 Million
-403,791 Reduced 24.01%
1,278,199 $73.4 Million
Q3 2017

Nov 03, 2017

BUY
$11.36 - $18.98 $19.1 Million - $31.9 Million
1,681,990
1,681,990 $82.3 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.